1. Home
  2. FGEN vs RAYA Comparison

FGEN vs RAYA Comparison

Compare FGEN & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • RAYA
  • Stock Information
  • Founded
  • FGEN 1993
  • RAYA 2019
  • Country
  • FGEN United States
  • RAYA China
  • Employees
  • FGEN N/A
  • RAYA N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • FGEN Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • FGEN 34.5M
  • RAYA 35.3M
  • IPO Year
  • FGEN 2014
  • RAYA 2022
  • Fundamental
  • Price
  • FGEN $0.50
  • RAYA $1.26
  • Analyst Decision
  • FGEN
  • RAYA
  • Analyst Count
  • FGEN 0
  • RAYA 0
  • Target Price
  • FGEN N/A
  • RAYA N/A
  • AVG Volume (30 Days)
  • FGEN 885.8K
  • RAYA 6.8K
  • Earning Date
  • FGEN 02-24-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • FGEN N/A
  • RAYA N/A
  • EPS Growth
  • FGEN N/A
  • RAYA N/A
  • EPS
  • FGEN N/A
  • RAYA N/A
  • Revenue
  • FGEN $180,015,000.00
  • RAYA $22,816,585.00
  • Revenue This Year
  • FGEN $21.91
  • RAYA $64.53
  • Revenue Next Year
  • FGEN N/A
  • RAYA $9.61
  • P/E Ratio
  • FGEN N/A
  • RAYA N/A
  • Revenue Growth
  • FGEN 16.15
  • RAYA N/A
  • 52 Week Low
  • FGEN $0.18
  • RAYA $0.50
  • 52 Week High
  • FGEN $2.93
  • RAYA $1.78
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 49.50
  • RAYA 47.39
  • Support Level
  • FGEN $0.46
  • RAYA $1.22
  • Resistance Level
  • FGEN $0.51
  • RAYA $1.44
  • Average True Range (ATR)
  • FGEN 0.05
  • RAYA 0.08
  • MACD
  • FGEN -0.01
  • RAYA -0.01
  • Stochastic Oscillator
  • FGEN 31.25
  • RAYA 37.93

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: